Using real-world evidence to complement evidence from randomized controlled trials on oral anticoagulants for stroke prevention

TL;DR

This paper explores how real-world data can support clinical trial findings for anticoagulants used in stroke prevention.

Contribution

The paper highlights the value of real-world evidence in complementing traditional clinical trial data for anticoagulant evaluation.

Findings

Real-world data can provide insights into anticoagulant effectiveness in diverse patient populations.

Complementing clinical trials with real-world evidence may improve understanding of long-term outcomes.

Abstract

Mark J. R. Smeets and Suzanne C. Cannegieter discuss the use of real world data to complement data generated by clinical trials of systemic anticoagulants.